KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Gains from Investment Securities: 2009-2025

Historic Gains from Investment Securities for Exact Sciences (EXAS) over the last 16 years, with Sep 2025 value amounting to $8.7 million.

  • Exact Sciences' Gains from Investment Securities rose 63.94% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.9 million, marking a year-over-year increase of 385.31%. This contributed to the annual value of -$3.3 million for FY2024, which is 81.46% up from last year.
  • Exact Sciences' Gains from Investment Securities amounted to $8.7 million in Q3 2025, which was up 77.29% from $4.9 million recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Gains from Investment Securities ranged from a high of $48.5 million in Q4 2021 and a low of -$40.5 million during Q3 2021.
  • Its 3-year average for Gains from Investment Securities is $42,000, with a median of $4.2 million in 2023.
  • Per our database at Business Quant, Exact Sciences' Gains from Investment Securities soared by 809.57% in 2021 and then tumbled by 598.30% in 2023.
  • Over the past 5 years, Exact Sciences' Gains from Investment Securities (Quarterly) stood at $48.5 million in 2021, then slumped by 97.94% to $1.0 million in 2022, then tumbled by 598.30% to -$5.0 million in 2023, then surged by 79.57% to -$1.0 million in 2024, then soared by 63.94% to $8.7 million in 2025.
  • Its Gains from Investment Securities was $8.7 million in Q3 2025, compared to $4.9 million in Q2 2025 and $8.3 million in Q1 2025.